No matter how cynical the overall market is, Dermata Therapeutics Inc (DRMA) performance over the last week is recorded 24.54%

A new trading day began on November 20, 2023, with Dermata Therapeutics Inc (NASDAQ: DRMA) stock priced at $0.6699, up 19.20% from the previous day of trading. During the day, the shares moved up to $0.8344 and dropped to $0.6452 before settling in for the closing price of $0.70. DRMA’s price has ranged from $0.56 to $11.84 over the past 52 weeks.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Meanwhile, its annual earnings per share averaged 69.68%. With a float of $2.79 million, this company’s outstanding shares have now reached $3.19 million.

Let’s determine the extent of company efficiency that accounts for 8 employees.

Dermata Therapeutics Inc (DRMA) Breakdown of a Key Holders of the stock

As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Dermata Therapeutics Inc is 12.49%, while institutional ownership is 4.29%.

Dermata Therapeutics Inc (DRMA) Recent Fiscal highlights

In its latest quarterly report, released on 9/29/2023, the company reported earnings of -$0.54 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.98 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 69.68% per share during the next fiscal year.

Dermata Therapeutics Inc (NASDAQ: DRMA) Trading Performance Indicators

Here are Dermata Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 7.99.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.61, a number that is poised to hit -0.78 in the next quarter and is forecasted to reach -2.35 in one year’s time.

Technical Analysis of Dermata Therapeutics Inc (DRMA)

Looking closely at Dermata Therapeutics Inc (NASDAQ: DRMA), its last 5-days average volume was 2.06 million, which is a jump from its year-to-date volume of 1.02 million. As of the previous 9 days, the stock’s Stochastic %D was 44.00%. Additionally, its Average True Range was 0.11.

During the past 100 days, Dermata Therapeutics Inc’s (DRMA) raw stochastic average was set at 22.59%, which indicates a significant decrease from 66.01% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 166.50% in the past 14 days, which was higher than the 89.95% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $0.8508, while its 200-day Moving Average is $1.7705. However, in the short run, Dermata Therapeutics Inc’s stock first resistance to watch stands at $0.8975. Second resistance stands at $0.9605. The third major resistance level sits at $1.0867. If the price goes on to break the first support level at $0.7083, it is likely to go to the next support level at $0.5821. Now, if the price goes above the second support level, the third support stands at $0.5191.

Dermata Therapeutics Inc (NASDAQ: DRMA) Key Stats

With a market capitalization of 2.66 million, the company has a total of 3,189K Shares Outstanding. Currently, annual sales are 0 K while annual income is -9,610 K. The company’s previous quarter sales were 0 K while its latest quarter income was -1,720 K.


On What Basis Did Swvl Holdings Corp (SWVL) Stock Rise 47% Pre-Hours?

When last checked, Swvl Holdings Corp. (Nasdaq: SWVL), a...

What Drove Organovo (ONVO) Stock Up 15% In After-Hour Session On Tuesday?

Shares of Organovo Holdings Inc. (Nasdaq: ONVO) were up...

Is There Any Reason As To Why The Zai Lab (ZLAB) Stock Expanded By 13%?

The biopharmaceutical business Zai Lab Limited (NASDAQ: ZLAB), which...



Don't miss

Wearable Devices (WLDS) Stock Rose 12% On Tuesday, But On What Basis?

Wearable Devices Ltd (NASD: WLDS) is experiencing significant growth...

Did Anything Boost ObsEva (OBSV) Stock In Pre-Hours Trading?

Following an update, shares of ObsEva SA (NASD: OBSV)...

How Did The Kalera (KAL) Stock Rise 32% Pre-Hours?

At the time of the most recent check, shares...

Why Has Selina Hospitality (SLNA) Stock Increased In Extended Session On Friday?

The stock of Selina Hospitality PLC (NASD: SLNA), which...

HashiCorp Inc (HCP) last year’s performance of -14.87% is a clear signal for an entertaining trading season.

On November 24, 2023, HashiCorp Inc (NASDAQ: HCP) opened at $20.87, higher 1.96% from the last session. During the day, the shares moved up...

Kyndryl Holdings Inc (KD) is ready for next Episode as it posted an annual sales of 17,026 M

A new trading day began on November 24, 2023, with Kyndryl Holdings Inc (NYSE: KD) stock priced at $18.05, down -0.39% from the previous...

Atmos Energy Corp. (ATO) is expecting -4.84% growth in the next quarter: What can investors do to maximize their returns?

Atmos Energy Corp. (NYSE: ATO) kicked off on November 24, 2023, at the price of $112.31, down -0.93% from the previous trading day. During...


Please enter your comment!
Please enter your name here